Xilio Therapeutics (XLO) Earnings Date & Reports

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

XLO is expected to report earnings to -57 cents per share on August 12

Xilio Therapeutics XLO Stock Earnings Reports

Q2'26

Est.

$-0.58

Q1'26

Missed

by $0.51

Q4'25

Beat

by $0.88

Q3'25

Missed

by $0.06

Q2'25

Missed

by $0.06

The last earnings report on May 12 showed earnings per share of -57 cents, missing the estimate of -6 cents. With 56.52K shares outstanding, the current market capitalization sits at 58.12M.

View a ticker or compare two or three

Compare

XLO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for XLO